|
|
The vaccine development and market news monitor, with emphasis on vaccine R&D, sales and marketing, while chronicling disruptive technologies and next-generation vaccine therapeutics.
|
|
Audience:
Corporate executives and R&D leaders at vaccine developers and pharmaceuticals of all sizes. |
Key Topics: Vaccine R&D, sales and marketing, research breakthroughs, vaccine production, disruptive technologies, next-generation vaccine therapeutics |
Newsletter Frequency: Weekly |
Email Subscribers: 30,000+ |
Monthly page views: 22,400 |
Reader Demographics
Company Type
Pharmaceutical - 27%
CRO/CMO/Contract Outsourcing - 22%
Biotechnology - 19%
Healthcare/Medical - 6%
Financial/Legal - 3%
Devices/Diagnostics - 2%
Instruments/Materials - 2%
IT/IS/Bioinformatics - 2%
Government - 1%
Other - 12%
Job Function
CEO / C-Level Executive - 20%
Clinical Operations - 12%
Licensing / Biz Dev - 10%
R&D / Engineering - 10%
Marketing / Brand Mgmt - 9%
Sales - 8%
Finance / Legal - 7%
Regulatory / Compliance / Safety - 4%
Manufacturing / Packaging - 3%
QA / QC - 2%
Medical Affairs - 2%
IT / IS / Bioinformatics - 2%
Other - 11%
Region
North America - 63%
Europe - 10%
Asia - 15%
Australia/NZ - 1%
Other - 11%
|
View Rates
Enter your contact information to see current rates and packages.
Top Companies Represented
Novartis
Amgen
Schering-Plough
Pfizer
AstraZeneca
GlaxoSmithKline
Wyeth
Merck
Iomai
|
